Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants

European Urology Focus(2025)10.1016/j.euf.2025.03.017Source: DataRank Database

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants is a research paper published in European Urology Focus (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (31 grants)OA: hybridTopics (23)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Shivakumar Keerthikumar ORCID,Scott L. Townley ORCID,Ashlee K. Clark,Georgia B. Cuffe ORCID,Geraldine Laven‐Law ORCID

Live enrichment

PubMed:40221372 PMC:PMC13180466

National Breast Cancer Foundation

Grant: MNBCF-17-012

Prostate Cancer Foundation of Australia

Grant: PIRA FLECR-0523

Hospital Research Foundation

Grant: 61120932

National Health and Medical Research Council

Grant: 1156570

National Health and Medical Research Council

Grant: 1138242

A novel strategy for targeting castrate-resistant prostate cancer

National Health and Medical Research Council

Grant: 44120498

National Health and Medical Research Council

Grant: 2011033

Cancer Australia

Grant: 2023_PCRS_0269

Cancer Australia

Grant: 2020336

Cancer Australia

Grant: 2001432

Victorian Cancer Agency

Grant: MCRF18017

Victorian Cancer Agency

Grant: MCRF15023

Cancer Council NSW

Grant: RG 23-04

National Cancer Institute

Grant: PRF2919

National Cancer Institute

Grant: R01CA174777

National Cancer Institute

Grant: R01CA256157

National Cancer Institute

Grant: R01CA234715

National Cancer Institute

Grant: R01CA270539

National Cancer Institute

Grant: PO1 CA163227

National Cancer Institute

Grant: P50CA097186

NCI NIH HHS

Grant: P01 CA163227

Cancer Council South Australia

Tasmanian Department of Health

Medical Research Future Fund

Monash University

E.J. Whitten Foundation

Movember Foundation

Cancer Council Victoria

Institute for Prostate Cancer Research

National Institutes of Health

U.S. Department of Health and Human Services

hybridLicense: CC BY

publisherhttps://api.elsevier.com/content/article/PII:S2405456925000732?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405456925000732?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC13180466

Europe_PMChttps://europepmc.org/articles/PMC13180466?pdf=render

https://doi.org/10.1016/j.euf.2025.03.017

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsHumansMiceReceptors, AndrogenGene Expression Regulation, NeoplasticMaleProstatic Neoplasms, Castration-Resistant

Keywords

Androgen receptorAndrogen deprivation therapyprostate cancerChromatin ImmunoprecipitationPatient-derived XenograftCistromeBipolar Androgen TherapyMaleGene Expression Regulation, NeoplasticProstatic Neoplasms, Castration-ResistantMiceReceptors, AndrogenHumansAnimals

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants

FAIR Checklist

Authors (22)

Funding (31 grants)

Open Access

Topics

Annotations (Europe PMC)